AstraZeneca
AZN
$67.83
Share price
1.21%
Change (1 day)
3.84%
Change (1 year)
Categories
AstraZeneca (AZN) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $59.12 B
According to AstraZeneca's latest financial reports the company's total liabilities are $59.12 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
AstraZeneca - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $59.42 B | -10.07% |
| 2021-12-31 | $66.07 B | 29.33% |
| 2020-12-31 | $51.09 B | 9.21% |
| 2019-12-31 | $46.78 B | 0.37% |
| 2018-12-31 | $46.60 B | -0.22% |
| 2017-12-31 | $46.71 B | 1.86% |
| 2016-12-31 | $45.85 B | 10.19% |
| 2015-12-31 | $41.61 B | 6.84% |
| 2014-12-31 | $38.94 B | 19.31% |
| 2013-12-31 | $32.64 B | 10.36% |
| 2012-12-31 | $29.58 B | 0.76% |
| 2011-12-31 | $29.35 B | -10.27% |
| 2010-12-31 | $32.71 B | -4.05% |
| 2009-12-31 | $34.09 B | 10.39% |
| 2008-12-31 | $30.89 B | -6.51% |
| 2007-12-31 | $33.04 B | 127.62% |
| 2006-12-31 | $14.51 B | 30.2% |
| 2005-12-31 | $11.14 B | -0.05% |
| 2004-12-31 | $11.15 B | 8.13% |
| 2003-12-31 | $10.31 B | -0.38% |
| 2002-12-31 | $10.35 B | -18.35% |
| 2001-12-31 | $12.68 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $125.10 B | 111.58% | 🇺🇸 USA |
 Novartis NVS | $59.04 B | -0.13% | 🇨🇭 Switzerland |
 Pfizer PFE | $94.38 B | 59.62% | 🇺🇸 USA |
 Abbott Laboratories ABT | $36.56 B | -38.16% | 🇺🇸 USA |
 Eli Lilly LLY | $43.66 B | -26.15% | 🇺🇸 USA |
 Sanofi SNY | $56.95 B | -3.67% | 🇫🇷 France |
 Biogen BIIB | $10.69 B | -81.91% | 🇺🇸 USA |
 Merck MRK | $60.89 B | 2.98% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $61.45 B | 3.94% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $59.66 B | 0.92% | 🇬🇧 UK |